Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts

FDA Drug Recalls

6,161 recalls · Class II, newest first

Class II · Moderate risk

20% Dextrose Injection

Lack of Assurance of Sterility: Hospira, Inc is voluntarily recalling the products due to possible leaking bags.

Terminated Sterility / contamination Hospira Inc. NDC 0409-7935-19 D-616-2013
Class II · Moderate risk

5% Dextrose Injection USP

Lack of Assurance of Sterility: Hospira, Inc is voluntarily recalling the products due to possible leaking bags.

Terminated Sterility / contamination Hospira Inc. NDC 0409-7922-02 D-614-2013
Class II · Moderate risk

70% Dextrose Injection USP

Lack of Assurance of Sterility: Hospira, Inc is voluntarily recalling the products due to possible leaking bags.

Terminated Sterility / contamination Hospira Inc. NDC 0409-7120-07 D-612-2013
Class II · Moderate risk

ChloraPrep One-Step

Lack of Assurance of Sterility: Firm mistakenly released quarantined, non conforming material that failed sterility testing.

Terminated Sterility / contamination Carefusion 213, Llc NDC 54365-400-01 D-004-2013
Class II · Moderate risk

Multihance Multipack

Lack of Assurance of Sterility; Product recalled due to displacement of the aluminum crimp cap during product usage.

Terminated Sterility / contamination Bracco Diagnostics Inc D-1665-2012
Class II · Moderate risk

ChloraPrep with Tint

Lack of Assurance of Sterility: A customer complaint reported some units had incomplete seals (open seals) on the Individual unit packaging.

Terminated Sterility / contamination Carefusion 213, Llc D-1674-2012
Class II · Moderate risk

Murocel (methylcellulose)

Lack of Assurance of Sterility: Bausch & Lomb, Inc. is recalling 7 Lots of Murocel Methylcellulose Lubricant Opthalmic Solution 1% (15 mL). Product was found to be OOS for Antimicrobial Effectiveness testing (AET) at the 12 month stability time point.

Terminated Sterility / contamination Bausch & Lomb, Inc. NDC 24208-280-15 D-1370-2012

Recalls by year